TASK is incredibly proud to contribute to this crucial research and remain dedicated to making a tangible difference in the lives of those affected by TB. Stay tuned for updates on this important study and learn more about UNITE4TB's vital work #TBResearch #UNITE4TB #TASK #EnableStudy #ClinicalTrials #GlobalHealth #EndTB
📢 UNITE4TB is pleased to announce that the ENABLE study is the latest trial to be added to its growing clinical trial program, marking another step forward in the fight against tuberculosis (TB) 💪 By integrating ENABLE, we are strengthening our commitment to accelerating the development of safer, more effective TB treatments. The study is being conducted under the collaboration between BioVersys AG and GSK, with clinical trial implementation led by TASK. 🔗 Read more 👉 https://lnkd.in/ewM2unXS #UNITE4TB #TBResearch #ClinicalTrials #GlobalHealth #YesWeCanEndTB #CommitInvestDeliver #PublicPrivatePartnership funded by the Innovative Medicines Initiative 2 (Innovative Health Initiative (IHI)). AMR Accelerator